Clinical Application of Self-Adherent Scar Care Silicone Sheet and Silicone Gel in Postoperative Scar Management

Abstract

Background: Hypertrophic scars and keloids result from burns, trauma, infection, and surgery and affect daily life. Although various scar management options are available, their efficacy remains uncertain. Silicone-based products, including sheets and gels, are the primary choices for scar management. This study assesses the effectiveness of Mepiform and Mepiform Ultra Scar Gel and their optimal use. Methods: Eighteen patients who underwent primary repair between January and June 2021 were enrolled and divided into those using both Mepiform products and those using only Mepiform Ultra Scar Gel. Scars were evaluated at baseline and after 2, 4, 8, 12, and 24 weeks. The Vancouver Scar Scale score was evaluated at 12 and 24 weeks. The patients provided feedback through a survey. Results: Group 1 (both Mepiform products) showed greater improvements in vascularity (33%), height (33%), and overall sum (67%) on the Vancouver Scar Scale from weeks 12 to 24. Group 2 (only Mepiform Ultra Scar Gel) showed improvements in vascularity (22%), height (22%), and overall sum (33%). Both groups reported positive outcomes, with group 1 demonstrating higher improvement percentages for most parameters. Conclusion: This study provides valuable insights into Mepiform and Mepiform Ultra Scar Gel in postoperative scar management despite a limited sample size. All scars in the study either remained stable or improved. Better results from group 1 suggest combining Mepiform products offers advantages. The consistent and prolonged use of silicone-based products is emphasized, and larger-scale research is needed to validate these findings.